Clinical Trial Update: Evaluate Safety and Efficacy of ABT-335 in Combination With Rosuvastatin Calcium in Subjects With Multiple Abnormal Lipid Levels in the Blood [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating safety and efficacy of ABT-335 in combination with rosuvastatin in subjects with multiple abnormal lipid levels has completed, with res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Heart Disease
• Dyslipidemia
• Mixed Dyslipidemia

Drugs mentioned

• ABT-335
• ROSUVASTATIN CALCIUM (rosuvastatin calcium)

Snippet

Sponsor: Abbott | Conditions: Dyslipidemia, Coronary Heart Disease | Phase 3 | Status: COMPLETED | Results posted: 2009-03-25